Skip to main content
. 2020 Jun 4;12(6):1674. doi: 10.3390/nu12061674

Table 2.

Remnant cholesterol levels by NAFLD severity and time in control subjects, whole sample, and adherent subjects.

NAFLD 1 Time Control Diet Intervention Subjects Adherent Subjects
N (%) Mean (SD) N (%) Mean (SD) N (%) Mean (SD)
Absent Baseline 12 (23.53) 0.67 (0.39) 30 (21.28) 0.87 (0.54) 18 (20.93) 0.80 (0.52)
3 months 22 (43.14) 0.80 (0.39) 54 (38.30) 0.75 (0.44) 30 (34.88) 0.71 (0.31)
6 months 17 (33.33) 0.61 (0.23) 57 (40.43) 0.71 (0.31) 38 (44.19) 0.73 (0.29)
Mild Baseline 14 (37.84) 0.94 (0.38) 30 (27.78) 0.95 (0.57) 20 (25.32) 0.93 (0.38)
3 months 12 (32.43) 0.79 (0.32) 44 (40.74) 0.77 (0.46) 33 (41.77) 0.72 (0.30)
6 months 11 (29.73) 0.92 (0.45) 34 (31.48) 0.76 (0.43) 26 (32.91) 0.71 (0.34) *
Moderate Baseline 24 (45.28) 0.96 (0.71) 75 (44.91) 1.05 (0.50) 45 (45.45) 1.08 (0.56)
3 months 15 (28.30 0.79 (0.44) 53 (31.74) 0.88 (0.44) 30 (30.30) 0.89 (0.53)
6 months 14 (26.42) 0.82 (0.39) 39 (23.35) 0.98 (0.47) 24 (24.24) 0.90 (0.50)
Severe Baseline 11 (44.0) 1.02 (0.52) 41 (46.07) 1.09 (0.63) 17 (48.57) 1.25 (0.81)
3 months 8 (32.0) 0.90 (0.39) 21 (23.60) 1.10 (0.53) 7 (20.00) 1.37 (0.67)
6 months 6 (24.0) 1.03 (0.54) 27 (30.34) 1.03 (0.51) 11 (31.43) 1.23 (0.65)

1 NAFLD: Non-Alcoholic Fatty Liver Disease. * Anova test p < 0.05.